Status:
COMPLETED
DOLORisk: Research on Risk Factors and Determinants for Neuropathic Pain
Lead Sponsor:
University of Kiel
Collaborating Sponsors:
Horizon 2020 - European Commission
Institut National de la Santé Et de la Recherche Médicale, France
Conditions:
Neuropathic Pain
Eligibility:
All Genders
18+ years
Brief Summary
Patients with neuropathic pain of multiple etiologies and a control cohort of patients with the same neuropathic entities who did not develop neuropathic pain are examined clinically, phenotyped with ...
Detailed Description
Patients with probable (presence of a combination of symptoms and signs of neuropathy include any two or more of the following: neuropathic symptoms, decreased distal sensation, or unequivocally decre...
Eligibility Criteria
Inclusion
- \- Diagnosis of Polyneuropathy
Exclusion
- Patients with polyneuropathy and possible neuropathic pain
- Patients with skin lesions or dermatological disorders in the areas to be tested upon QST
- Patients with any painful or neurological comorbidity that could otherwise influence testing results such as vascular disease, radiculopathy, spinal canal stenosis etc.
Key Trial Info
Start Date :
June 1 2015
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
June 1 2019
Estimated Enrollment :
1550 Patients enrolled
Trial Details
Trial ID
NCT04888455
Start Date
June 1 2015
End Date
June 1 2019
Last Update
November 8 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University of Kiel
Kiel, Schleswig-Holstein, Germany, 24105